أعرض في EDS

Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response

التفاصيل البيبلوغرافية
العنوان:	Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response
المؤلفون:	Hana Šváchová, Pavel Nemec, L. Kovarova, Zdenek Adam, Miroslav Penka, Ludek Pour, Lucie Burešová, Martina Almáši, Roman Hájek, Tomas Buchler, Jiri Vorlicek
المساهمون:	Departement of Internal Medicine-Hematooncology, University Hospital Brno, Czech Myeloma Group, University Research Centre, Institute of Biostatistics and Analyses [Brno] (IBA MED / MUNI), Faculty of Medicine [Brno] (MED / MUNI), Masaryk University [Brno] (MUNI)-Masaryk University [Brno] (MUNI), Departement of Oncology, 1st Faculty of Medicine and Thomayer University Hospital, Departement of Clinical Hematology
المصدر:	Annals of Hematology Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩
بيانات النشر:	Springer Science and Business Media LLC, 2009.
سنة النشر:	2009
مصطلحات موضوعية:	Adult, Male, Vascular Endothelial Growth Factor A, medicine.medical_specialty, Therapeutic response, Angiogenesis, Basic fibroblast growth factor, Antineoplastic Agents, Thrombospondin 1, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, High-dose chemotherapy, medicine, Humans, Angiostatins, Aged, 030304 developmental biology, 0303 health sciences, Angiostatin, Hepatocyte Growth Factor, business.industry, Hematology, General Medicine, Middle Aged, 3. Good health, Vascular endothelial growth factor, Vascular endothelial growth factor A, Treatment Outcome, medicine.anatomical_structure, Endocrinology, chemistry, 030220 oncology & carcinogenesis, Cytokines, Female, Hepatocyte growth factor, Bone marrow, Endostatin, Multiple Myeloma, business, medicine.drug
الوصف:	International audience; Angiogenesis plays a significant role in the pathogenesis of multiple myeloma (MM). We have measured concentrations of angiogenesis activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and hepatocyte growth factor (HGF), and inhibitors, including endostatin, thrombospondin-1 (TSP-1), and angiostatin in the peripheral and bone marrow blood of MM patients at diagnosis and after high-dose chemotherapy. We have analyzed 96 patients with secretory MM. Serial measurements of angiogenesis factors/inhibitors were analyzed in the plasma by subgroups based on the best treatment response. Concentrations of angiogenic factors were determined in the peripheral blood and bone marrow plasma. There were significant decreases of VEGF and HGF levels and a significant increase in TSP-1 concentrations in the bone marrow plasma of patients who achieved complete or very good partial response in contrast to those who had partial or no response. VEGF and HGF levels decrease but those of TSP-1 increase after successful treatment for MM, indicating a reduction in the rate of angiogenesis.
تدمد:	1432-0584 0939-5555
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcb8937e6a0978c97664bbcd161e80eTest https://doi.org/10.1007/s00277-009-0834-3Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi.dedup.....6dcb8937e6a0978c97664bbcd161e80e
قاعدة البيانات:	OpenAIRE

ResultId	1
Header	edsair OpenAIRE edsair.doi.dedup.....6dcb8937e6a0978c97664bbcd161e80e 792 3 unknown 792.104064941406
PLink	https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6dcb8937e6a0978c97664bbcd161e80e&custid=s6537998&authtype=sso
FullText	Array ( [Availability] => 0 )
Items	Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response ) Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Hana+Šváchová%22">Hana Šváchová</searchLink><br /><searchLink fieldCode="AR" term="%22Pavel+Nemec%22">Pavel Nemec</searchLink><br /><searchLink fieldCode="AR" term="%22L%2E+Kovarova%22">L. Kovarova</searchLink><br /><searchLink fieldCode="AR" term="%22Zdenek+Adam%22">Zdenek Adam</searchLink><br /><searchLink fieldCode="AR" term="%22Miroslav+Penka%22">Miroslav Penka</searchLink><br /><searchLink fieldCode="AR" term="%22Ludek+Pour%22">Ludek Pour</searchLink><br /><searchLink fieldCode="AR" term="%22Lucie+Burešová%22">Lucie Burešová</searchLink><br /><searchLink fieldCode="AR" term="%22Martina+Almáši%22">Martina Almáši</searchLink><br /><searchLink fieldCode="AR" term="%22Roman+Hájek%22">Roman Hájek</searchLink><br /><searchLink fieldCode="AR" term="%22Tomas+Buchler%22">Tomas Buchler</searchLink><br /><searchLink fieldCode="AR" term="%22Jiri+Vorlicek%22">Jiri Vorlicek</searchLink> ) Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Departement of Internal Medicine-Hematooncology<br />University Hospital Brno<br />Czech Myeloma Group<br />University Research Centre<br />Institute of Biostatistics and Analyses [Brno] (IBA MED / MUNI)<br />Faculty of Medicine [Brno] (MED / MUNI)<br />Masaryk University [Brno] (MUNI)-Masaryk University [Brno] (MUNI)<br />Departement of Oncology<br />1st Faculty of Medicine and Thomayer University Hospital<br />Departement of Clinical Hematology ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Annals of Hematology<br />Annals of Hematology, Springer Verlag, 2009, 89 (4), pp.385-389. ⟨10.1007/s00277-009-0834-3⟩ ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Springer Science and Business Media LLC, 2009. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2009 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Vascular+Endothelial+Growth+Factor+A%22">Vascular Endothelial Growth Factor A</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Emedical%5Fspecialty%22">medicine.medical_specialty</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutic+response%22">Therapeutic response</searchLink><br /><searchLink fieldCode="DE" term="%22Angiogenesis%22">Angiogenesis</searchLink><br /><searchLink fieldCode="DE" term="%22Basic+fibroblast+growth+factor%22">Basic fibroblast growth factor</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+Agents%22">Antineoplastic Agents</searchLink><br /><searchLink fieldCode="DE" term="%22Thrombospondin+1%22">Thrombospondin 1</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%22chemistry%2Echemical%5Fcompound%22">chemistry.chemical_compound</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Internal+medicine%22">Internal medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Antineoplastic+Combined+Chemotherapy+Protocols%22">Antineoplastic Combined Chemotherapy Protocols</searchLink><br /><searchLink fieldCode="DE" term="%22High-dose+chemotherapy%22">High-dose chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%22">medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Angiostatins%22">Angiostatins</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22030304+developmental+biology%22">030304 developmental biology</searchLink><br /><searchLink fieldCode="DE" term="%220303+health+sciences%22">0303 health sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Angiostatin%22">Angiostatin</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatocyte+Growth+Factor%22">Hepatocyte Growth Factor</searchLink><br /><searchLink fieldCode="DE" term="%22business%2Eindustry%22">business.industry</searchLink><br /><searchLink fieldCode="DE" term="%22Hematology%22">Hematology</searchLink><br /><searchLink fieldCode="DE" term="%22General+Medicine%22">General Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%223%2E+Good+health%22">3. Good health</searchLink><br /><searchLink fieldCode="DE" term="%22Vascular+endothelial+growth+factor%22">Vascular endothelial growth factor</searchLink><br /><searchLink fieldCode="DE" term="%22Vascular+endothelial+growth+factor+A%22">Vascular endothelial growth factor A</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Eanatomical%5Fstructure%22">medicine.anatomical_structure</searchLink><br /><searchLink fieldCode="DE" term="%22Endocrinology%22">Endocrinology</searchLink><br /><searchLink fieldCode="DE" term="%22chemistry%22">chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22030220+oncology+%26+carcinogenesis%22">030220 oncology & carcinogenesis</searchLink><br /><searchLink fieldCode="DE" term="%22Cytokines%22">Cytokines</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatocyte+growth+factor%22">Hepatocyte growth factor</searchLink><br /><searchLink fieldCode="DE" term="%22Bone+marrow%22">Bone marrow</searchLink><br /><searchLink fieldCode="DE" term="%22Endostatin%22">Endostatin</searchLink><br /><searchLink fieldCode="DE" term="%22Multiple+Myeloma%22">Multiple Myeloma</searchLink><br /><searchLink fieldCode="DE" term="%22business%22">business</searchLink><br /><searchLink fieldCode="DE" term="%22medicine%2Edrug%22">medicine.drug</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => International audience; Angiogenesis plays a significant role in the pathogenesis of multiple myeloma (MM). We have measured concentrations of angiogenesis activators, including vascular endothelial growth factor (VEGF), basic fibroblast growth factor, and hepatocyte growth factor (HGF), and inhibitors, including endostatin, thrombospondin-1 (TSP-1), and angiostatin in the peripheral and bone marrow blood of MM patients at diagnosis and after high-dose chemotherapy. We have analyzed 96 patients with secretory MM. Serial measurements of angiogenesis factors/inhibitors were analyzed in the plasma by subgroups based on the best treatment response. Concentrations of angiogenic factors were determined in the peripheral blood and bone marrow plasma. There were significant decreases of VEGF and HGF levels and a significant increase in TSP-1 concentrations in the bone marrow plasma of patients who achieved complete or very good partial response in contrast to those who had partial or no response. VEGF and HGF levels decrease but those of TSP-1 increase after successful treatment for MM, indicating a reduction in the rate of angiogenesis. ) Array ( [Name] => ISSN [Label] => ISSN [Group] => ISSN [Data] => 1432-0584<br />0939-5555 ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcb8937e6a0978c97664bbcd161e80e" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcb8937e6a0978c97664bbcd161e80e</link><br /><link linkTarget="URL" linkTerm="https://doi.org/10.1007/s00277-009-0834-3" linkWindow="_blank">https://doi.org/10.1007/s00277-009-0834-3</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....6dcb8937e6a0978c97664bbcd161e80e )
RecordInfo	Array ( [BibEntity] => Array ( [Languages] => Array ( [0] => Array ( [Text] => Undetermined ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 5 [StartPage] => 385 ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Adult [Type] => general ) [1] => Array ( [SubjectFull] => Male [Type] => general ) [2] => Array ( [SubjectFull] => Vascular Endothelial Growth Factor A [Type] => general ) [3] => Array ( [SubjectFull] => medicine.medical_specialty [Type] => general ) [4] => Array ( [SubjectFull] => Therapeutic response [Type] => general ) [5] => Array ( [SubjectFull] => Angiogenesis [Type] => general ) [6] => Array ( [SubjectFull] => Basic fibroblast growth factor [Type] => general ) [7] => Array ( [SubjectFull] => Antineoplastic Agents [Type] => general ) [8] => Array ( [SubjectFull] => Thrombospondin 1 [Type] => general ) [9] => Array ( [SubjectFull] => 03 medical and health sciences [Type] => general ) [10] => Array ( [SubjectFull] => chemistry.chemical_compound [Type] => general ) [11] => Array ( [SubjectFull] => 0302 clinical medicine [Type] => general ) [12] => Array ( [SubjectFull] => Internal medicine [Type] => general ) [13] => Array ( [SubjectFull] => Antineoplastic Combined Chemotherapy Protocols [Type] => general ) [14] => Array ( [SubjectFull] => High-dose chemotherapy [Type] => general ) [15] => Array ( [SubjectFull] => medicine [Type] => general ) [16] => Array ( [SubjectFull] => Humans [Type] => general ) [17] => Array ( [SubjectFull] => Angiostatins [Type] => general ) [18] => Array ( [SubjectFull] => Aged [Type] => general ) [19] => Array ( [SubjectFull] => 030304 developmental biology [Type] => general ) [20] => Array ( [SubjectFull] => 0303 health sciences [Type] => general ) [21] => Array ( [SubjectFull] => Angiostatin [Type] => general ) [22] => Array ( [SubjectFull] => Hepatocyte Growth Factor [Type] => general ) [23] => Array ( [SubjectFull] => business.industry [Type] => general ) [24] => Array ( [SubjectFull] => Hematology [Type] => general ) [25] => Array ( [SubjectFull] => General Medicine [Type] => general ) [26] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [27] => Array ( [SubjectFull] => 3. Good health [Type] => general ) [28] => Array ( [SubjectFull] => Vascular endothelial growth factor [Type] => general ) [29] => Array ( [SubjectFull] => Vascular endothelial growth factor A [Type] => general ) [30] => Array ( [SubjectFull] => Treatment Outcome [Type] => general ) [31] => Array ( [SubjectFull] => medicine.anatomical_structure [Type] => general ) [32] => Array ( [SubjectFull] => Endocrinology [Type] => general ) [33] => Array ( [SubjectFull] => chemistry [Type] => general ) [34] => Array ( [SubjectFull] => 030220 oncology & carcinogenesis [Type] => general ) [35] => Array ( [SubjectFull] => Cytokines [Type] => general ) [36] => Array ( [SubjectFull] => Female [Type] => general ) [37] => Array ( [SubjectFull] => Hepatocyte growth factor [Type] => general ) [38] => Array ( [SubjectFull] => Bone marrow [Type] => general ) [39] => Array ( [SubjectFull] => Endostatin [Type] => general ) [40] => Array ( [SubjectFull] => Multiple Myeloma [Type] => general ) [41] => Array ( [SubjectFull] => business [Type] => general ) [42] => Array ( [SubjectFull] => medicine.drug [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Hana Šváchová ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pavel Nemec ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => L. Kovarova ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zdenek Adam ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Miroslav Penka ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ludek Pour ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lucie Burešová ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Martina Almáši ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Roman Hájek ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Tomas Buchler ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Jiri Vorlicek ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Departement of Internal Medicine-Hematooncology ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => University Hospital Brno ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Czech Myeloma Group ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => University Research Centre ) ) ) [15] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Institute of Biostatistics and Analyses [Brno] (IBA MED / MUNI) ) ) ) [16] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Faculty of Medicine [Brno] (MED / MUNI) ) ) ) [17] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Masaryk University [Brno] (MUNI)-Masaryk University [Brno] (MUNI) ) ) ) [18] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Departement of Oncology ) ) ) [19] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => 1st Faculty of Medicine and Thomayer University Hospital ) ) ) [20] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Departement of Clinical Hematology ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 26 [M] => 09 [Type] => published [Y] => 2009 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 14320584 ) [1] => Array ( [Type] => issn-print [Value] => 09395555 ) [2] => Array ( [Type] => issn-locals [Value] => edsair ) [3] => Array ( [Type] => issn-locals [Value] => edsairFT ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 89 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Annals of Hematology [Type] => main ) ) ) ) ) ) )
IllustrationInfo